Saturday 17 October 2026 Export GSK’s income statement to Excel — free account

GSK PLC Sponsored ADR

GSK Healthcare Drug Manufacturers General

GSK PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $43.1 billion, up 7.44% from fiscal 2024. In the quarter to June 2026, revenue grew 5.81%, EPS fell 69.5%, free cash flow grew 54.8% and total debt rose 5.61%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

49.55 0.53 +1.08%

Follow GSK

Alert me

Market cap: $98.2B
P/E: 15.4×
Fwd P/E: 12.4×
Dividend yield: 3.67%
F-score: 9/9
Altman Z: 2.12
Beneish M: −2.46
Dividend safety: 54/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	16.33	14.26	13.22	12.16	+8 more quarters Free account
P/S ratio Full definition →	2.36	2.53	2.31	2.07
P/FCF ratio Full definition →	13.76	16.97	15.39	13.52
P/Operating CF Full definition →	29.19	72.20	34.92	28.68
P/B ratio Full definition →	4.56	4.73	4.72	4.10
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	2.82	3.01	2.74	2.53
EV/EBITDA Full definition →	9.80	9.85	8.74	7.57
EV/Operating CF Full definition →	11.38	12.81	11.56	10.38
EV/FCF Full definition →	16.40	20.17	18.29	16.52
Quick Ratio Full definition →	0.52	0.51	0.53	0.55
Current Ratio Full definition →	0.82	0.79	0.82	0.84
Net Debt/EBITDA Full definition →	5.43	5.63	21.84	4.28
Debt/Assets Full definition →	29.54%	30.31%	28.99%	28.94%
Debt/Equity Full definition →	1.06	1.09	1.11	1.13
Asset Turnover Full definition →	0.55	0.54	0.55	0.53
Operating CF/Net income Full definition →	6.17	0.66	3.34	1.12
Capex/Depreciation Full definition →	(0.16)	(0.76)	2.08	(1.12)
Interest Coverage Full definition →	2.64	13.73	5.90	15.53
Research and Development Expense of Revenue Full definition →	41.22%	22.18%	27.15%	19.76%
Selling, General and Administrative Expense of Revenue Full definition →	26.19%	27.78%	30.64%	26.20%
Intangible Assets out of Total Assets Full definition →	0.39	0.40	0.39	0.39
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Graham Net Nets Full definition →	(0.34)	(0.34)	(0.37)	(0.43)
Graham Number Full definition →	28.80	31.88	29.45	29.00
Earnings Yield Full definition →	6.12%	7.01%	7.57%	8.23%
Free Cash Flow Yield Full definition →	7.27%	5.89%	6.50%	7.40%
Revenue per Share Full definition →	5.62	5.11	5.64	5.71
Operating CF per Share Full definition →	1.80	0.76	1.40	1.50
Capex per Share Full definition →	(0.24)	(0.24)	(0.63)	(0.57)
Free Cash Flow per Share Full definition →	1.56	0.53	0.77	0.94
Cash per Share Full definition →	2.14	2.36	2.30	2.28
Shareholders Equity per Share Full definition →	11.49	11.67	10.39	10.53
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	11.49	11.67	10.39	10.53
Free Cash Flow Full definition →	3,126.87	1,060.48	1,567.56	1,893.07
Working Capital Full definition →	(5,334.85)	(6,290.13)	(5,117.87)	(4,706.87)
Capital Expenditures Full definition →	(477.22)	(477.01)	(1,276.93)	(1,141.83)
Net Current Asset Value Full definition →	(36,239.39)	(37,306.88)	(36,464.69)	(37,397.49)
EV/EBIT Full definition →	14.41	12.26	11.29	10.73
Capex to Sales Full definition →	0.04	0.05	0.11	0.10
Price to Operating Income Full definition →	12.09	10.32	9.50	8.78
Other line items
Average Receivables Full definition →	10,558.12	10,071.31	9,796.20	10,712.39
Average Payables Full definition →	19,521.00	19,198.29	19,939.76	19,912.23
Average Inventory Full definition →	8,270.42	7,926.78	7,528.20	7,971.70
Average Assets Full definition →	81,001.78	80,586.97	78,292.04	79,088.69
Average Common Equity Full definition →	21,112.23	20,336.68	18,881.89	19,364.55

Show all line items

Columns are period end dates

Stockrow Weekly